SCHEMBL29640336

SCHEMBL29640336

CCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A5 Q9Y345 2/20 0.68
NOD1 Q9Y239 9/20 0.59
CTSL P07711 1/20 0.56
FAAH O00519 2/20 0.50
NMT2 O60551 1/20 0.49
NMT1 P30419 1/20 0.49
FURIN P09958 1/20 0.49
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
TLR2 O60603 1/20 0.48
SIRT6 Q8N6T7 1/20 0.47
SIRT1 Q96EB6 1/20 0.47
FOLH1 Q04609 1/20 0.47
MEN1 O00255 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30496949 1.00 SLC6A5 (0.68) SLC6A5NOD1CTSLFAAHNMT2
SCHEMBL29640314 1.00 SLC6A5 (0.68) SLC6A5NOD1CTSLFAAHNMT2
SCHEMBL30496969 1.00 SLC6A5 (0.68) SLC6A5NOD1CTSLFAAHNMT2
SCHEMBL445569 0.95 SLC6A5 (0.66) SLC6A5NOD1CTSLNMT2NMT1
SCHEMBL443317 0.95 SLC6A5 (0.66) SLC6A5NOD1CTSLNMT2NMT1
Acetic Acid SCHEMBL25220206 0.93 SLC6A5 (0.64) SLC6A5NOD1CTSLNMT2NMT1
Acetic Acid SCHEMBL30391850 0.93 SLC6A5 (0.64) SLC6A5NOD1CTSLNMT2NMT1
SCHEMBL29520919 0.93 SLC6A5 (0.64) SLC6A5NOD1CTSLNMT2NMT1
SCHEMBL13811916 0.92 SLC6A5 (0.59) SLC6A5NOD1CTSLFAAHNMT2
SCHEMBL29640368 0.90 SLC6A5 (0.65) SLC6A5NOD1CTSLFAAHNMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116979-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE NISSAN CHEMICAL CORPORATION (JP) 2024-04-11 US disclosed
US-20240067675-A1 METHOD FOR PRODUCING LIPID PEPTIDE NISSAN CHEMICAL CORPORATION (JP) 2024-02-29 US disclosed
EP-4265629-A1 METHOD FOR PRODUCING LIPID PEPTIDE Nissan Chemical Corporation (JP) 2023-10-25 EP disclosed
CN-116648455-A Method for preparing lipid peptide 日产化学株式会社 2023-08-25 CN disclosed
CN-116615435-A Method for preparing lipid peptide 日产化学株式会社 2023-08-18 CN disclosed
WO-2022138957-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE 日産化学株式会社 2022-06-30 WO disclosed
WO-2022138953-A1 METHOD FOR PRODUCING LIPID PEPTIDE 日産化学株式会社 2022-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067675-A1 METHOD FOR PRODUCING LIPID PEPTIDE VIP, NGLY1, NPPA SLC6A5 1803/4885NOD1 4121/4885CTSL 1684/4885
US-20240116979-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE NPPA, VIP, NGLY1 SLC6A5 1172/4885NOD1 4139/4885CTSL 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.